Aim: The aim of this study was to identify whether mannose-binding lectin (MBL) and C-reactive protein (CRP) may be used as clinical biomarkers for predicting outcome of community-acquired pneumonia (CAP) by tracking serum MBL and CRP level changes during a time course. Methods: One hundred four patients with CAP and 100 healthy individuals were enrolled in this study. The patients were further divided into Survivor and Death groups based on 30-day mortality. The MBL and CRP levels in these patients at pre- and post-treatments at days 4 and 7 were determined using an immunoturbidimetric assay and an enzyme-linked immunosorbent assay (ELISA). Results: Compared to the control group, the MBL and CRP levels in the CAP group were significantly higher. CRP levels in the CAP group significantly reduced within 1 week following anti-infection and other supporting therapies including anti-phlegm and liquidation. MBL levels were significantly higher in the Survivor group than in the Death group (p<0.05). On the contrary, CRP levels were significantly higher in the Death group than in the Survivor group (p<0.05). There was a negative correlation between the serum MBL and CRP levels in all patients following the treatments. Conclusion: Both the MBL and CRP can serve as inflammatory markers in predicting the outcome of patients with CAP.
Get full access to this article
View all access options for this article.
References
1.
AittoniemiJ, RintalaE, MiettinenA, et al. (1997) Serum mannan-binding lectin (MBL) in patients with infection: clinical and laboratory correlates. APMIS, 105:617-622.
2.
AlmirallJ, BolibarI, ToranP, et al. (2004) Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest, 125:1335-1342.
3.
AngusDC, MarrieTJ, ObroskyDS, et al. (2002) Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med, 166:717-723.
4.
BafadhelM, ClarkTW, ReidC, et al. (2011) Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Chest, 139:1410-1418.
5.
BohlsonSS, FraserDA, TennerAJ (2007) Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions. Mol Immunol, 44:33-43.
6.
DeanMM, MinchintonRM, HeatleyS, et al. (2005) Mannose binding lectin acute phase activity in patients with severe infection. J Clin Immunol, 25:346-352.
7.
EisenDP, DeanMM, BoermeesterMA, et al. (2008) Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis, 47:510-516.
8.
FalkG, FaheyT (2009) C-reactive protein and community-acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies. Fam Pract, 26:10-21.
9.
FrakkingFN, IsraelsJ, KremerLC, et al. (2011) Mannose-binding lectin (MBL) and the risk for febrile neutropenia and infection in pediatric oncology patients with chemotherapy. Pediatr Blood Cancer, 57:89-96.
10.
FraserDA, BohlsonSS, JasinskieneN, et al. (2006) C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J Leukoc Biol, 80:107-116.
11.
Garcia-LaordenMI, Sole-ViolanJ, Rodriguez de CastroF, et al. (2008) Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. J Allergy Clin Immunol, 122:368-374; 374.e361-e362.
12.
GarredP, PresslerT, LanngS, et al. (2002) Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease. Pediatr Pulmonol, 33:201-207.
13.
HohenthalU, HurmeS, HeleniusH, et al. (2009) Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia. Clin Microbiol Infect, 15:1026-1032.
14.
HoriuchiT, GondoH, MiyagawaH, et al. (2005) Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT. Genes Immun, 6:162-166.
15.
JoffeE, JustoD, MashavN, et al. (2009) C-reactive protein to distinguish pneumonia from acute decompensated heart failure. Clin Biochem, 42:1628-1634.
16.
Julian-JimenezA, Palomo de Los ReyesMJ, SentenacJG, et al. (2010) [Usefulness of procalcitonin and C-reactive protein in community-acquired pneumonia in the emergency department]. Enferm Infecc Microbiol Clin, 28:666-667.
17.
JustoD, LachmiS, SaarN, et al. (2009) C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia. Eur J Intern Med, 20:518-521.
18.
KravitzMS, PitashnyM, ShoenfeldY (2005) Protective molecules—C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity. J Clin Immunol, 25:582-591.
19.
KwokCS, LokeYK, WooK, et al. (2013) Risk prediction models for mortality in community-acquired pneumonia: a systematic review. Biomed Res Int, 2013:504136
20.
NavratilovaZ, GalloJ, MrazekF, et al. (2012) MBL2 gene variation affecting serum MBL is associated with prosthetic joint infection in Czech patients after total joint arthroplasty. Tissue Antigens, 80:444-451.
21.
NethO, JackDL, JohnsonM, et al. (2002) Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. J Immunol, 169:4430-4436.
22.
NseirW, FarahR, MograbiJ, et al. (2013) Impact of serum C-reactive protein measurements in the first 2 days on the 30-day mortality in hospitalized patients with severe community-acquired pneumonia: a cohort study. J Crit Care, 28:291-295.
23.
OgdenCA, deCathelineauA, HoffmannPR, et al. (2001) C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med, 194:781-795.
24.
PandaAK, ParidaJR, TripathyR, et al. (2012) Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity. Arthritis Res Ther, 14:R218
25.
Perez-CastellanoM, PenarandaM, PayerasA, et al. (2006) Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumonia. Clin Exp Immunol, 145:228-234.
26.
RabinovitchRA, KoetheSM, KalbfleischJH, et al. (1986) Relationships between alternative complement pathway activation, C-reactive protein, and pneumococcal infection. J Clin Microbiol, 23:56-61.
27.
RamirezJA; Community-Acquired Pneumonia Organization Investigators (2005) Worldwide perspective of the quality of care provided to hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study. Semin Respir Crit Care Med, 26:543-552.
28.
SureshMV, SinghSK, FergusonDAJr., et al. (2006) Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection. J Immunol, 176:4369-4374.
29.
TakataS, WadaH, TamuraM, et al. (2011) Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times. Biomarkers, 16:530-535.
30.
ThiemU, NiklausD, SehlhoffB, et al. (2009) C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia. Age Ageing, 38:693-697.
31.
TrouwLA, BlomAM, GasqueP (2008) Role of complement and complement regulators in the removal of apoptotic cells. Mol Immunol, 45:1199-1207.
32.
ValdimarssonH (2003) Infusion of plasma-derived mannan-binding lectin (MBL) into MBL-deficient humans. Biochem Soc Trans, 31:768-769.
33.
van der ZwetWC, CatsburgA, van ElburgRM, et al. (2008) Mannose-binding lectin (MBL) genotype in relation to risk of nosocomial infection in pre-term neonates in the neonatal intensive care unit. Clin Microbiol Infect, 14:130-135.
34.
WangM, ChenY, ZhangY, et al. (2011) Mannan-binding lectin directly interacts with Toll-like receptor 4 and suppresses lipopolysaccharide-induced inflammatory cytokine secretion from THP-1 cells. Cell Mol Immunol, 8:265-275.
